Axsome Therapeutics (NASDAQ:AXSM – Get Free Report) had its target price boosted by stock analysts at Mizuho from $212.00 to ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible resultsSome results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback